Please login to the form below

Not currently logged in
Email:
Password:

Sprout Pharma

This page shows the latest Sprout Pharma news and features for those working in and with pharma, biotech and healthcare.

Valeant swoops on Sprout to claim female sexual disorder drug

Valeant swoops on Sprout to claim female sexual disorder drug

The ink was barely dry on the FDA's approval of Sprout Pharma's controversial 'little pink pill' Addyi before Valeant announced a $1bn deal to buy the company. ... The Sprout deal comes after its $11bn purchase of gastrointestinal drug specialist Salix

Latest news

  • FDA panel backs Sprout Pharma's 'female Viagra' FDA panel backs Sprout Pharma's 'female Viagra'

    FDA panel backs Sprout Pharma's 'female Viagra'. Could be approved for HSDD in pre-menopausal women. ... drug. Sprout acquired rights to the programme in 2011 and says it hopes to market it under the Addyi trade name.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics